West pharmaceutical services, inc. raises earnings guidance for the full year 2019

West pharmaceutical services, inc. raised earnings guidance for the full year 2019. the company is raising its full-year 2019 net sales guidance to a new range of between $1.815 billion and $1.825 billion, compared to the prior guidance range of between $1.810 billion and $1.825 billion. organic sales growth is expected to be approximately 8%. net sales guidance includes a headwind of $54 million for the full-year 2019 based on current foreign exchange rates, compared to prior guidance of a full-year negative impact of $42 million.
WST Ratings Summary
WST Quant Ranking